| Ingredients | Amount Per Serving |
|---|---|
|
(Artemisia dracunculus Leaf Extract, Dry)
(Extraction Rate: About 1/3-4. We used up to 333mg of raw material to produce 1ml of Extract)
|
1156 mg |
Glycerin, Water
Below is general information about the effectiveness of the known ingredients contained in the product Tarragon Non-Alcohol. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
INSUFFICIENT RELIABLE EVIDENCE to RATE
Below is general information about the safety of the known ingredients contained in the product Tarragon Non-Alcohol. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
LIKELY SAFE ...when the leaf or essential oil is used orally in amounts commonly found in foods. Tarragon has Generally Recognized as Safe (GRAS) status in the US (4912). There is insufficient reliable information available about the safety of tarragon when used orally or topically in medicinal amounts, or when used by inhalation for aromatherapy.
PREGNANCY AND LACTATION: LIKELY UNSAFE
Insufficient reliable information is available; avoid using.
Below is general information about the interactions of the known ingredients contained in the product Tarragon Non-Alcohol. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
Evidence from in vitro research suggests that tarragon extract inhibits platelet aggregation and adhesion (49445,76932,77038). Theoretically, tarragon might increase the risk of bleeding when used with antiplatelet or anticoagulant drugs. Some anticoagulant or antiplatelet drugs include aspirin, clopidogrel (Plavix), dalteparin (Fragmin), enoxaparin (Lovenox), heparin, ticlopidine (Ticlid), warfarin (Coumadin), and others.
|
Evidence from animal research suggests that tarragon essential oil can cause sedation and motor impairment when administered intraperitoneally at a dose of 1 mL/kg (77024). Theoretically, concomitant use of tarragon with CNS depressants, including antihistamines, barbiturates, benzodiazepines, and tricyclic antidepressants, may increase sedative and other adverse effects.
|
In vitro research suggests that tarragon extract inhibits monoamine oxidase (MAO)-A and MAO-B enzymes (106774). Theoretically, concomitant use with MAOIs might increase the effects and adverse effects associated with MAOIs.
|
Below is general information about the adverse effects of the known ingredients contained in the product Tarragon Non-Alcohol. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
General ...No adverse effects have been reported. However, a thorough evaluation of safety outcomes has not been conducted. There is concern that long-term consumption of estragole, a constituent of tarragon, increases the risk for cancer. However, this risk has only been shown in animals (77046,77029,77042).
